Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a valuable class of drugs in the management of type 2 diabetes mellitus. These agents simulate the actions of naturally occurring GLP-1, stimulating https://antonuuto477782.ja-blog.com/36090974/emerging-glucagon-like-peptide-1-receptor-agonists-a-comprehensive-review